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Acute Respiratory Distress Syndrome from Tick-borne
Human Granulocytic Anaplasmosis Infection
Vedang Patel, MD

Introduction
Tick-borne infections were first formally recognized over
a century ago, but it was only in 1990 that the first case
of human granulocytic anaplasmosis (HGA), a tick-borne
infection caused by Anaplasma phagocytophilum, was
identified.1,2 Like other tick-borne infections, HGA presents
as a nonspecific febrile illness. The most common clinical
features are fever, headache, myalgia and malaise.2 This
case report presents a rare but serious complication of
HGA – acute respiratory distress syndrome (ARDS).

CASE PRESENTATION
A 49-year-old female with no past medical history
presented to her local emergency department with
complaints of fevers, headache, neck pain, myalgia,
and malaise. She denied symptoms of upper respiratory
tract infection, diarrhea, dysuria, rashes, and bleeding or
bruising. She worked as an administrative assistant and
lived on a farm in a rural area of Pennsylvania. She was in
a monogamous relationship. She drank alcohol socially,
and she was not known to use any illicit drugs.
Her vital signs were temperature of 102 degrees Fahrenheit,
pulse of 100 beats per minute, oxygen saturation of 98%
on room air, and respiratory rate of 18 breaths per minute.
On physical examination, she appeared fatigued but was
alert and oriented to person, place, and time. There were
no focal neurologic deficits. Her oropharynx was clear.
Her neck was supple with full range of motion. Brudzinski
and Kernig test were negative. Her lungs were clear to
auscultation. Cardiac exam revealed tachycardia but no
murmurs, rubs, or gallops. Her abdomen was soft and
non-tender. There were no stigmata of liver disease. She
had no rashes and no cutaneous bleeding. There were
no palpable lymph nodes.
Laboratory evaluation revealed a white blood cell count of
2 x109/L (normal range = 4-11 x109/L), platelet count of 43
x109/L (normal range = 140-400 x109/L), and hemoglobin
of 11 g/dL (normal range = 14-17 g/dL). Her liver function
panel revealed an aspartate aminotransferase (AST) of 923
U/L (normal range = 7-42 U/L) and alanine aminotrans-
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ferase (ALT) of 946 U/L (normal range = 1-45 U/L). Her
bilirubin and alkaline phosphatase were mildly elevated.
The patient was admitted for Systemic Inflammatory
Response Syndrome (SIRS). She was empirically started
on vancomycin and piperacillin-tazobactam. On her first
day of admission she developed hypoxemic respiratory
failure. A chest x-ray showed bilateral airspace opacities
without evidence of volume overload. Mechanical
ventilation was initiated and doxycycline was added. She
was transferred to Thomas Jefferson University Hospital
for management of ARDS.

DIFFERENTIAL DIAGNOSIS
The patient's high fevers and acute onset of symptoms
suggested an infectious etiology. Cerebrospinal fluid
testing was negative for viral, fungal, and bacterial
pathogens. Bronchoalveolar lavage was lymphocytepredominant, and testing for viral, fungal, and bacterial
respiratory pathogens was also negative. A right upper
quadrant abdominal ultrasound was unremarkable.
Given that she lived on a farm with deer nearby and the
laboratory findings of leukopenia, thrombocytopenia,
and elevated liver enzymes, there was concern for a
tick-borne infection. Blood tests for Lyme, Ehrlichia,
Babesia, and Rocky Mountain Spotted Fever (RMSF)
were negative. Serum IgM and IgG for Anaplasma
were negative, but Anaplasma DNA testing via real time
polymerase chain reaction (PCR) was positive.

OUTCOME AND FOLLOW-UP
The patient was ventilated per the ARDS protocol, with a
tidal volume of 6 mL/kg. Once the diagnosis of HGA was
confirmed, vancomycin and piperacillin-tazobactam were
discontinued and doxycycline, the treatment of choice
for Anaplasma, was continued. After three days in the
medical intensive care unit the patient was successfully
extubated. At the time of discharge her blood cell counts
had normalized and her liver enzymes were improving.
Her chest x-ray demonstrated resolution of the bilateral
airspace opacities. The patient was discharged home to
complete a 14-day course of oral doxycycline.
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DISCUSSION
HGA is characterized by a febrile illness that most often
presents with headache, myalgia, and fatigue. The first case
of HGA in a human was in 1990 when a Wisconsin man
died two weeks after being bitten by a tick. In the United
States, the Centers for Disease Control and Prevention
has recorded 2135 cases between 1994 and 2002, the last
year for complete data.2,3 The incidence of HGA is rising
and cases are often unreported. ARDS, the most serious
complication seen in this patient's clinical course, has been
reported in less than 1% of cases of HGA.4
ARDS is characterized by hypoxemic respiratory failure,
radiographic evidence of bilateral airspace opacities
without volume overload, and an arterial oxygen
pressure (PaO2) to inspired oxygen fraction (FiO2) ratio
of less than 300 mmHg. Sepsis, aspiration, pneumonia,
and trauma are the most common causes of ARDS.5,6
Patients require high levels of oxygen supplementation
during the first several days, and clinical improvement
usually depends on treatment of the underlying cause.
Unlike traditional mechanical ventilation strategies that
use 10 to 15 mL/kg of tidal volume, a low tidal volume
approach of 6 to 8 mL/kg has been shown to decrease
mortality and improve clinical outcomes in patients with
ARDS.6 The consequences of ARDS include impaired gas
exchange, decreased lung compliance, and pulmonary
hypertension.7 Thus, it is imperative to make a diagnosis
of the underlying cause and to begin immediate treatment.
The diagnosis of HGA is often difficult because symptoms
develop days after the tick bite but seroconversion takes 2
to 4 weeks. If testing for antibodies is being considered,
2 serum samples should be taken at least 2 to 3 weeks
apart and a 4-fold rise in antibody titer is needed to make
the diagnosis. A Wright- or Giemsa-stained peripheral
blood smear may provide early diagnosis by detecting
morulae in neutrophils.2 Confirmation of HGA now often
relies on PCR testing. but PCR is not readily available at all
facilities. Therefore diagnosis often relies on clinical signs
and symptoms, and treatment should not be delayed
for confirmation of diagnosis. HGA infection is most
common in the spring and summer months. The vector
for transmission is the deer tick Ixodes scapularis.1 The
highest incidence in the United States is in the northeast
and north central states. Laboratory findings suggestive of
HGA are leukopenia (present in 50% of cases), thrombocytopenia (94%), and transaminitis (90%).2 This patient
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had all of the common laboratory features, presented in
late spring, and lived in the northeast United States.
The treatment of choice for adults with HGA is
doxycycline at a dose of 100 mg orally every 12 hours
for 7 to 14 days. In patients who are pregnant or have a
tetracycline allergy, rifampin at 300 mg twice daily may
be substituted.2,8 Symptoms start to resolve within 24
to 48 hours, and in patients who do not show clinical
improvement a co-existing Babesia infection should be
considered.2 Treatment with doxycycline and a low tidal
volume mechanical ventilation strategy were pivotal to
this patient's favorable outcome.

KEY POINTS
Headache, myalgia, and fatigue are the most common
symptoms of HGA. Seroconversion takes two weeks so
PCR testing is the test of choice for diagnosis. If suspicion
for HGA is high, treatment with doxycycline should not
be delayed for confirmation of diagnosis. ARDS is a very
rare complication of HGA. Treatment with doxycycline
and a low-tidal volume mechanical ventilation strategy
were essential for the favorable outcome in this patient.
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